AstraZeneca reveals new research to improve drug discovery
The study used data from 50,000 people in the UK Biobank
Read More
Tag: UK Biobank
Scientists discover 59 repurposing drug candidates for COVID-19
An analysis of UK Biobank datasets by PrecisionLife has found 13 ‘druggable’ targets
Read More
Imperial and Bayer to use AI for heart conditions
Researchers at Imperial and Bayer Pharmaceuticals are partnering up to explore how artificial intelligence (AI) can be used to accelerate the discovery of new drugs for heart conditions.
Read More
UK Biobank attracts backing from GSK and Regeneron
GlaxoSmithKline and Regeneron have given their backing to a new project that will use patient data held by the UK Biobank.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
